Phenylacetonitrile → 3-Phenyl-5-(2-phenyl-2H-pyrazol-3-yl)-benzo[c]isoxazole
Reaction equation
[N+:1]([C:4]1[CH:9]=[CH:8][C:7]([C:10]2[N:14]([C:15]3[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=3)[N:13]=[CH:12][CH:11]=2)=[CH:6][CH:5]=1)([O-:3])=O.[C:21]1([CH2:27]C#N)[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=1>>[C:21]1([C:27]2[O:3][N:1]=[C:4]3[CH:9]=[CH:8][C:7]([C:10]4[N:14]([C:15]5[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=5)[N:13]=[CH:12][CH:11]=4)=[CH:6][C:5]=23)[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=1Participants
3
Procedure
The title compound, light grey solid (37 mg, 29%), MS (ISP) m/z=338.3 [(M+H)+], mp 163° C., was prepared in accordance with the general method of example 1 from 5-(4-nitro-phenyl)-1-phenyl-1H-pyrazole (intermediate A) (100 mg, 353 μmol) and commercially available 2-phenyl-acetonitrile.
Sources & evidence
- ORD record
- ord-6205c395f8cb41608996a9d2a6bc054c
- Source dataset
- uspto-grants-2016_09
- Patent number
- US09440962B2
Reaction notes
Loading…